A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Medical Director
Merck Sharp & Dohme LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
290 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro de Oncologia E Investigacion Buenos Aires Coiba ( Site 0136)
Berazategui, Buenos Aires, Argentina
Recruiting - Instituto Alexander Fleming ( Site 0125)
Mar del Plata, Buenos Aires, Argentina
Recruiting - Instituto de Investigaciones Clinicas Mar del Plata ( Site 0129)
Mar del Plata, Buenos Aires, Argentina
Recruiting - Sanatorio Parque ( Site 0126)
Rosario, Santa Fe Province, Argentina
Recruiting - Centro Medico Dra de Salvo ( Site 0132)
CABA, Argentina
Recruiting - Fundación Cori Para la Investigación Y Prevención del Cáncer ( Site 0131)
La Rioja, Argentina
Recruiting - Centro Oncologico de Integracion Regional. Coir ( Site 0130)
Mendoza, Argentina
Recruiting - Centro de Diagnostico Investigación Y Tratamiento Oncológico (cedit) ( Site 0135)
Salta, Argentina
Recruiting - Instituto San Marcos ( Site 0137)
San Juan, Argentina
Recruiting
- Blacktown Hospital ( Site 0154)
Blacktown, New South Wales, Australia
Recruiting - Macquarie University-Mq Health Clinical Trials Unit ( Site 0151)
Macquarie University, New South Wales, Australia
Recruiting - Gallipoli Medical Research Ltd ( Site 0153)
Greenslopes, Queensland, Australia
Recruiting - Peter Maccallum Cancer Centre ( Site 0152)
Melbourne, Victoria, Australia
Recruiting - Fiona Stanley Hospital ( Site 0155)
Murdock, Western Australia, Australia
Recruiting
- Ordensklinikum Linz Gmbh Elisabethinen-Urologie ( Site 0170)
Linz, Upper Austria, Austria
Recruiting - Klinikum Wels-Grieskirchen Gmbh ( Site 0171)
Wels, Upper Austria, Austria
Recruiting - Uniklinikum Salzburg Universitaetsklinik Für Innere Medizin Iii ( Site 0172)
Salzburg, Austria
Recruiting
- Hospital Mario Penna ( Site 0179)
Belo Horizonte, Minas Gerais, Brazil
Recruiting - Hospital Universitário Evangélico Mackenzie ( Site 0181)
Curitiba, Paraná, Brazil
Recruiting - Irmandade Da Santa Casa de Misericórdia de Porto Alegre ( Site 0184)
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Hospital de Base de São José Do Rio Preto ( Site 0176)
São José do Rio Preto, São Paulo, Brazil
Recruiting - Ibcc - Núcleo de Pesquisa E Ensino ( Site 0183)
São Paulo, Brazil
Recruiting - Ipitec ( Site 0189)
São Paulo, Brazil
Recruiting
- Bradfordhill ( Site 0200)
Santiago, Region M. de Santiago, Chile
Recruiting - Falp ( Site 0201)
Santiago, Region M. de Santiago, Chile
Recruiting
- Peking University First Hospital ( Site 1434)
Beijing, Beijing Municipality, China
Recruiting - Shanghai General Hospital ( Site 1449)
Beijing, Beijing Municipality, China
Recruiting - Chongqing University Three Gorges Hospital ( Site 1405)
Chongqing, Chongqing Municipality, China
Recruiting - the First Affiliated Hospital of Chonqing Medical University ( Site 1406)
Chongqing, Chongqing Municipality, China
Recruiting - the First Affiliated Hospital of Fujian Medical University ( Site 1452)
Fuzhou, Fujian, China
Recruiting - Guangzhou First People'S Hospital ( Site 1410)
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen University Cancer Center ( Site 1467)
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University ( Site 1402)
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen University Cancer Center ( Site 1409)
Guangzhou, Guangdong, China
Recruiting - the Fifth Affiliated Hospital of Sun Yat-Sen University ( Site 1459)
Zhuhai, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital ( Site 1414)
Nanning, Guangxi, China
Recruiting - Henan Cancer Hospital ( Site 1472)
Zhengzhou, Henan, China
Recruiting - Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1424)
Wuhan, Hubei, China
Recruiting - Hunan Cancer Hospital ( Site 1411)
Changsha, Hunan, China
Recruiting - Jiangsu Province Hospital ( Site 1426)
Nanjing, Jiangsu, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 May 2025
- Primary completion
- 26 Jun 2028
- Completion
- 6 Jan 2031
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 1,440
- Registry id
- NCT06925737
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.